checkAd
    Amphastar Pharmaceuticals Aktie
    42,46
     
    USD
    -0,47 %
    -0,20 USD
    Letzter Kurs 04.05.24 Nasdaq
    42,42
     
    USD
    300 STK
    Geldkurs 03.05.24
    42,47
     
    USD
    200 STK
    Briefkurs 03.05.24
    ISIN: US03209R1032 · WKN: A11664 · SYM: AMPH · USA

    Neueste Nachrichten

    Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
    30.04.24 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
    01.04.24 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
    06.03.24 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
    28.02.24 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
    20.02.24 · Accesswire · Amphastar Pharmaceuticals
    Fokus Aktien mit extremen Handelsvolumen am Montag, den 22.01.2024
    22.01.24 · wO Chartvergleich · Archer Daniels Midland Company
    Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
    20.11.23 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
    09.11.23 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023
    08.11.23 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023
    01.11.23 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes
    13.09.23 · Accesswire · Amphastar Pharmaceuticals
    Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes
    11.09.23 · Accesswire · Amphastar Pharmaceuticals